Your browser doesn't support javascript.
loading
Calcium intake and genetic variants in the calcium sensing receptor in relation to colorectal cancer mortality: an international consortium study of 18,952 patients.
Wesselink, Evertine; Gauderman, William; Berndt, Sonja I; Brenner, Hermann; Buchanan, Daniel D; Campbell, Peter T; Chan, Andrew T; Chang-Claude, Jenny; Cotterchoi, Michelle; Gunter, Marc J; Hoffmeister, Michael; Joshi, Amit D; Newton, Christina C; Pai, Rish K; Pellatt, Andrew J; Phipps, Amanda I; Song, Mingyang; Um, Caroline Y; van Guelpen, Bethany; White, Emily; Peters, Ulrike; van Duijnhoven, Fränzel J B.
Afiliação
  • Wesselink E; Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.
  • Gauderman W; Division of Biostatistics, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA USA.
  • Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD USA.
  • Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Buchanan DD; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Campbell PT; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chan AT; Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, VIC Australia.
  • Chang-Claude J; University of Melbourne Centre for Cancer Research, The University of Melbourne, Parkville, VIC Australia.
  • Cotterchoi M; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, VIC Australia.
  • Gunter MJ; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY USA.
  • Hoffmeister M; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA USA.
  • Joshi AD; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA.
  • Newton CC; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA USA.
  • Pai RK; Broad Institute of Harvard and MIT, Cambridge, MA USA.
  • Pellatt AJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA USA.
  • Phipps AI; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Song M; University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany.
  • Um CY; Prevention and Cancer Control, Cancer Care Ontario, Toronto, ON Canada.
  • van Guelpen B; Dalla Lana School of Public Health, University of Toronto, Toronto, ON Canada.
  • White E; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Peters U; Department of Epidemiology and Biostatistics School of Public Health Imperial College London, London, UK.
  • van Duijnhoven FJB; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
BJC Rep ; 2(1): 63, 2024.
Article em En | MEDLINE | ID: mdl-39233917
ABSTRACT

Background:

Research on calcium intake as well as variants in the calcium sensor receptor (CaSR) gene and their interaction in relation to CRC survival is still limited.

Methods:

Data from 18,952 CRC patients, were included. Associations between primarily pre-diagnostic dietary (n = 13.085), supplemental (n = 11,837), total calcium intake (n = 5970) as well as 325 single nucleotide polymorphisms (SNPs) of the CaSR gene (n = 15,734) in relation to CRC-specific and all-cause mortality were assessed using Cox proportional hazard models. Also interactions between calcium intake and variants in the CaSR gene were assessed.

Results:

During a median follow-up of 4.8 years (IQR 2.4-8.4), 6801 deaths occurred, of which 4194 related to CRC. For all-cause mortality, no associations were observed for the highest compared to the lowest sex- and study-specific quartile of dietary (HR 1.00, 95%CI 0.92-1.09), supplemental (HR 0.97, 95%CI 0.89-1.06) and total calcium intake (HR 0.99, 95%CI 0.88-1.11). No associations with CRC-specific mortality were observed either. Interactions were observed between supplemental calcium intake and several SNPs of the CaSR gene.

Conclusion:

Calcium intake was not associated with all-cause or CRC-specific mortality in CRC patients. The association between supplemental calcium intake and all-cause and CRC-specific mortality may be modified by genetic variants in the CaSR gene.

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Idioma: En Revista: BJC Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Idioma: En Revista: BJC Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda